Print

AVEG 019

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) May 04, 1995
p17/p24:Ty- VLP Gag p17 and p24
p17/p24:Ty- VLP Virus Like Particles
USA 36
NCT00001053
https://clinicaltrials.gov/show/NCT00001053